Jpmorgan Chase & Co »

Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8M 50k 96.42
2023-06-30 $6.7M 77k 86.68
2023-03-31 $4.9M 51k 97.24
2022-12-31 $8.8M 85k 103.49
2022-06-30 $8.6M 104k 82.87
2021-03-31 $3.3M 43k 75.51
2020-12-31 $31M 353k 87.69
2020-09-30 $8.4M 111k 76.00
2020-06-30 $3.1M 25k 123.35
2020-03-31 $8.5M 100k 84.50
2019-12-31 $2.3M 27k 84.56
2019-03-31 $1.3M 14k 88.87
2018-12-31 $2.6M 30k 85.16
2018-09-30 $4.8M 50k 96.98
2018-06-30 $8.9M 94k 94.20
2018-03-31 $4.1M 50k 81.08
2017-12-31 $4.5M 50k 89.18
2016-09-30 $5.6M 60k 92.52

Top funds holding Biomarin Pharmaceutical